From the Journals

Hypertension in children linked to lower neurocognitive performance


 

Children with primary hypertension demonstrated significantly lower performance on neurocognitive testing, compared with children without primary hypertension, according to Marc B. Lande, MD, of the University of Rochester (N.Y.), and his associates.

kzenon/Thinkstock

Young girl getting blood pressure taken

In the study, 75 children with newly diagnosed untreated primary hypertension and 75 normotensive control subjects were examined. Hypertension was linked with worse performances on neurocognitive measures of attention, learning, memory, and fine motor dexterity, compared with the controls. There also was an association between increased disordered sleep and worse executive function. This was more pronounced in children with hypertension than in normotensive children. Hypertension and control groups did not differ significantly in age, sex, maternal education, income, race, ethnicity, obesity, anxiety, depression, cholesterol, glucose, insulin, and C-reactive protein.

“These results suggest that hypertension in youth may have an impact on brain function, and perhaps brain development, in childhood,” the researchers concluded. “Future results from this study will assess the degree to which these effects can be minimized or reversed with antihypertensive therapies.”

Find the full study in the Journal of Pediatrics (2016 Sept 29. doi: 10.1016/j.jpeds.2016.08.076).

Recommended Reading

CABG best for diabetes patients with CKD – or is it?
MDedge Cardiology
Reimbursement hurdles hinder Entresto use in HFrEF
MDedge Cardiology
Heart failure risk with individual NSAIDs examined in study
MDedge Cardiology
Medical quality beats patient comfort
MDedge Cardiology
Genes that drive glucose levels also drive heart disease
MDedge Cardiology
High-performing hospitals yield longer life expectancy after MI
MDedge Cardiology
No increase in CV events with long-acting bronchodilators in COPD
MDedge Cardiology
Cerebral protection in TAVI reduces ischemic brain lesions
MDedge Cardiology
Rivaroxaban linked to more bleeding compared with dabigatran in elderly patients with nonvalvular AF
MDedge Cardiology
Elevated troponins are serious business, even without an MI
MDedge Cardiology